Israeli company OncoHost, the developer of an AI-powered personalized cancer therapy platform, announced on Tuesday that it raised $8 million in Series B funding led by OurCrowd.
Read more here.
Israeli company OncoHost, the developer of an AI-powered personalized cancer therapy platform, announced on Tuesday that it raised $8 million in Series B funding led by OurCrowd.
Read more here.
![[OurCrowd in Forbes] Exploring the growing Asia-Israel links for venture capital and fund-raising](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
